Millipore and Gen-Probe Form Collaboration to Develop Rapid Molecular Tests for the Biotech and Pharmaceutical Industries
Millipore and Gen-Probe announced that the companies have formed an alliance to develop, manufacture and commercialize on an exclusive basis nucleic acid testing (NAT) products for rapid microbiological and virus monitoring in the biotech and pharmaceutical industries. Microbiological monitoring of manufacturing processes is critical to ensuring patient safety and meeting regulatory requirements.
Millipore's sample preparation technology can isolate a single microorganism from large volumes of fluid. Gen-Probe's NAT technology can amplify and detect minuscule quantities of microorganism-specific RNA in hours or less. The companies believe that the combination of both technologies is ideal for rapid molecular-based microbiological testing in biotech and pharmaceutical manufacturing.
Under the terms of the agreement, Gen-Probe will be primarily responsible for assay development and manufacturing, while Millipore will manage worldwide commercialization. The companies expect to launch the first of a series of new rapid biological testing products in 2007.
Most read news
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.